Adipositas - Ursachen, Folgeerkrankungen, Therapie 2025; 19(03): 182
DOI: 10.1055/s-0045-1810486
DOI: 10.1055/s-0045-1810486
Abstracts
Short Talks | Diagnostik, Therapie und Versorgung der Adipositas
Early-Onset of Obesity-Model: Auswirkungen einer frühzeitigen Gewichtsreduktion auf die Lebenserwartung und das Risiko von Begleiterkrankungen bei einem Patienten mit schwerer, früh auftretender Adipositas
Authors
-
M Wabitsch
1 University of Ulm, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm, Deutschland -
U C Wiedemann
2 Stradoo GmbH, München, Deutschland -
E van den Akker
3 Division of Pediatric Endocrinology, Department of Pediatrics, Sophia Children’s Hospital and Obesity Center CGG, Erasmus University Medical Center, Rotterdam, Niederlande -
T M Barber
4 Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire, Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, Großbritannien -
K Clément
5 Nutrition Department, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital Paris, Sorbonne University, Inserm, Nutrition and Obesity, Systemic Approaches (NutriOmique) Research Group, Paris, Frankreich -
S Farooqi
6 University of Cambridge, Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, Cambridge, Großbritannien -
A P Goldstone
7 Imperial College London, PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, London, Griechenland -
C Marcus
8 Karolinska Institutet Solna, Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Solna, Schweden -
L Moreno Aznar
9 University of Zaragoza, Growth, Exercise, Nutrition and Development (GENUD) Research Group, School of Health Science (EUCS), University of Zaragoza, Zaragoza, Spanien -
C Poitou Bernet
10 Nutrition Department, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital Paris, Sorbonne University, Inserm, Nutrition and Obesity, Systemic Approaches (NutriOmique) Research Group, Paris, Frankreich -
J L Schorfheide
11 Stradoo GmbH, München, Deutschland -
N Touchot
12 Rhythm Pharmaceuticals, Inc., Boston, USA -
P Kühnen
13 Charité – Universitätsmedizin Berlin, Institute for Experimental Pediatric Endocrinology, Berlin, Deutschland